ReviewMolecules (Basel, Switzerland)2022
State of the Art on Green Route Synthesis of Gold/Silver Bimetallic Nanoparticles.
Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Tailoring innovative silver nanoparticles for modern medicine: The importance of size and shape control and functional modifications.Materials today. Bio · 2025Review
- Controlled Synthesis of Bimetallic Gold-Silver Nanostars: Atomic Insights and Predictive Formation Model.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
- Bimetallic nanoparticles as pioneering eco-friendly catalysts for remediation of pharmaceuticals and personal care products (PPCPs).Nanoscale advances · 2025Review
- Cellulose Membranes Embedded with Gold-Silver Bimetallic Nanoparticles for the Efficient Reduction of 4-Nitrophenol.ACS omega · 2025Article
- Green-synthesized metal nanoparticles: a promising approach for accelerated wound healing.Frontiers in bioengineering and biotechnology · 2025Review
- Antimicrobial and scavenging potential of green synthesized silver/manganese bimetallic nanoparticles usingPeerJ · 2025Article
- Green synthesis trends and potential applications of bimetallic nanoparticles towards the sustainable development goals 2030.Nanoscale advances · 2023Review
- Article
- Synthesis of Au-Ag bimetallic nanoparticles using Korean red ginseng (Panax ginseng Meyer) root extract for chemo-photothermal anticancer therapy.Archives of pharmacal research · 2023Article
- Biofabrication of nanoparticles: sources, synthesis, and biomedical applications.Frontiers in bioengineering and biotechnology · 2023Review
- Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy.Molecules (Basel, Switzerland) · 2022Review
- Green Chemistry and Molecularly Imprinted Membranes.Membranes · 2022Review
- Supramolecular assembly of pentamidine and polymeric cyclodextrin bimetallic core-shell nanoarchitectures.Beilstein journal of nanotechnology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, bimetallic nanoparticles (BMNPs) blending the properties of two metals in one nanostructured system have generated enormous interest due to their potential applications in various fields including biosensing, imaging, nanomedicine, and catalysis. BMNPs have been developed later with respect to the monometallic nanoparticles (MNPs) and their physicochemical and biological properties have not yet been comprehensively explored. The manuscript aims at collecting the main design criteria used to synthetize BMNPs focusing on green route synthesis. The influence of experimental parameters such as temperature, time, reagent concentrations, capping agents on the particle growth and colloidal stability are examined. Finally, an overview of their nanotechnological applications and biological profile are presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.